Quantitative imaging is poised to make precision medicine a clinical reality

A review argues quantitative imaging biomarkers—not just qualitative reads—are key to unlocking precision medicine, moving beyond one-size-fits-all treatment by extracting mineable data from routine CT, MRI, and PET scans.

• This is a narrative review, not a primary study with new patient data, summarizing the potential of radiomics and AI-driven image analysis.
• The report emphasizes extracting quantitative data from standard-of-care images to characterize tumor heterogeneity and treatment response longitudinally.
• A major limitation acknowledged is the current lack of standardization and prospective validation required for routine clinical adoption of many quantitative imaging biomarkers.

RadPigeon summaries are original and for information only. They are not clinical advice.